Construction of a Mouse Model for Myeloproliferative Neoplasms and an Evaluation System.
10.19746/j.cnki.issn.1009-2137.2023.04.028
- Author:
Shu-Jin WANG
1
,
2
,
3
;
Xiang-Ru YU
1
,
2
,
3
;
Qi-Gang ZHANG
1
,
2
,
3
;
Yan-Jie LI
1
,
2
,
3
;
Chun-Ling FU
1
,
2
,
3
;
Kai-Lin XU
1
,
2
,
4
Author Information
1. Blood Diseases Institute, Xuzhou Medical University
2. Jiangsu Key Laboratory of Bone Marrow Stem Cells
3. Xuzhou 221000, Jiangsu Province, China.
4. Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, Jiangsu Province, China.E-mail: lihmd@163.com.
- Publication Type:Journal Article
- Keywords:
evaluation indicators;
mouse model;
myeloproliferative neoplasms
- MeSH:
Female;
Mice;
Animals;
Primary Myelofibrosis;
Myeloproliferative Disorders/genetics*;
Bone Marrow/pathology*;
Mutation;
Disease Models, Animal;
Neoplasms;
Janus Kinase 2/genetics*
- From:
Journal of Experimental Hematology
2023;31(4):1113-1118
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To construct a myeloproliferative neoplasms (MPN) transplanted mouse model with JAK2-V617F, MPLW515L or CALR-Type I gene mutation, and establish a systematic evaluation system to verify the success of model construction.
METHODS:The bone marrow c-kit+ cells of the mice were obtained by the following steps: The mice were killed by cervical dislocation, the femur, tibia and ilium were separated, and the bone marrow cells were collected. The c-kit+ cells were sorted after incubation with CD117 magnetic beads. The method of constructing mouse primary mutant cells is as follows: A gene mutation vector with a GFP tag was constructed by the retroviral system, and the retroviral vector was packaged into the Platinum-E cells to obtain the virus supernatant, and then used it to infect the c-kit+ cells of mice. The MPN mouse model was constructed as follows: the mouse primary c-kit+ cells containing the mutant genes were collected after infection, and then transplanted them via the tail vein into the female recipient mice of the same species which were irradiated with a lethal dose of gamma rays (8.0 Gy). The MPN mouse model was evaluated as follows: After transplantation, the peripheral blood of the mice was regularly collected from the tail vein to perform the complete blood count test, and the size of spleen and the degree of bone marrow fibrosis were estimated.
RESULTS:The mouse c-kit+ cells with the mutant genes were successfully obtained from the bone marrow. MPN mouse model was successfully constructed: The peripheral blood cells of the MPN-transplanted mice carried exogenous implanted GFP-positive cells, and the white blood cells (WBC), platelet (PLT) and hematocrit (HCT) were all increased; the body weight loss, and the water and food intake were reduced in the transplanted mice; further pathological analysis showed that the transplanted mice displayed splenomegaly and bone marrow fibrosis. These results suggested that the MPN mouse model was successfully constructed. According to the common and different characteristics of the three MPN mouse model, a preliminary evaluation system for judging the success of MPN mouse model construction was summarized, which mainly included the following indicators, for example, the proportion of GFP-positive cells in the peripheral blood of mice; WBC, PLT and HCT; the degree of spleen enlargement and the bone marrow fibrosis.
CONCLUSION:The MPN mouse model with JAK2-V617F, MPLW515L or CALR-Type I gene mutation is successfully established by retroviral system, which can provide an important experimental animal model for the research of MPN pathogenesis and drug-targeted therapy.
